Tetrahydrobiopterin compounds prolong allograft survival independently of their effect on nitric oxide synthase activity

Transplantation

Volumn 81, Issue 4, 2006, Pages 583-589

  Brandacher, Gerald ^a   Maglione, Manuel ^a   Schneeberger, Stefan ^a   Obrist, Peter ^b   Thoeni, Guntram ^a   Wrulich, Oliver A ^a   Werner Felmayer, Gabriele ^a   Margreiter, Raimund ^a   Werner, Ernst R ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Immunosuppression; Murine cardiac allograft; Nitric oxide; Tetrahydrobiopterin

Indexed keywords

3 NITROTYROSINE; 4 AMINO TETRAHYDROBIOPTERIN; CD163 ANTIGEN; CD3 ANTIGEN; CHEMOKINE; CYCLOSPORIN A; CYTOKINE; GAMMA INTERFERON; GELATINASE A; GRANZYME B; IA ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 2 RECEPTOR BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; N6 (1 IMINOETHYL)LYSINE; NITRATE; NITRIC OXIDE SYNTHASE; NITRITE; PEROXYNITRITE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; T LYMPHOCYTE RECEPTOR BETA CHAIN; TETRAHYDROBIOPTERIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GRAFT SURVIVAL; HEART FUNCTION; HEART TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; ISOGRAFT; MALE; MICROARRAY ANALYSIS; MONONUCLEAR CELL; MOUSE; NONHUMAN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BIOPTERIN; GRAFT SURVIVAL; HEART TRANSPLANTATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NITRATES; NITRIC OXIDE SYNTHASE; NITRITES; TRANSPLANTATION, HOMOLOGOUS;

EID: 33644615780     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188949.03683.fd     Document Type: Article

References (38)

1. Lindenfeld J, Miller GG, Shakar SF, et al. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation 2004; 110: 3734.
2. Lindenfeld J, Miller GG, Shakar SF, et al. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation 2004; 110: 3858.
3. Pieper GM, Halligan NL, Hilton G, et al. Non-heme iron protein: a potential target of nitric oxide in acute cardiac allograft rejection. Proc Natl Acad Sci U S A 2003; 100: 3125.
4. Worrall NK, Lazenby WD, Misko TP, et al. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995; 181: 63.
5. Bell RM, Maddock HL, Yellon DM. The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. Cardiovasc Res 2003; 57: 405.
6. Yin DP, Sankary HN, Chong AS, et al. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 1998; 66: 152.
7. Worrall NK, Misko TP, Sullivan PM, et al. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann Thorac Surg 1996; 62: 378.
8. Bastian NR, Xu S, Shao XL, et al. N omega -monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Biochim Biophys Acta 1994; 1226: 225.
9. Paul LC, Myllarniemi M, Muzaffar S, Benediktsson H. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat. Transplantation 1996; 62: 1193.
10. Werner ER, Pitters E, Schmidt K, et al. Identification of the 4-amino analogue of tetrahydrobiopterin as a dihydropteridine reductase inhibitor and a potent pteridine antagonist of rat neuronal nitric oxide synthase. Biochem J 1996; 320(Pt 1): 193.
11. Schmidt K, Werner-Felmayer G, Mayer B, Werner ER. Preferential inhibition of inducible nitric oxide synthase in intact cells by the 4-amino analogue of tetrahydrobiopterin. Eur J Biochem 1999; 259: 25.
12. Gibraeil HD, Dittrich P, Saleh S, Mayer B. Inhibition of endotoxin-induced vascular hyporeactivity by 4-amino-tetrahydrobiopterin. Br J Pharmacol 2000; 131: 1757.
13. Bahrami S, Fitzal F, Peichl G, et al. Protection against endotoxemia in rats by a novel tetrahydrobiopterin analogue. Shock 2000; 13: 386.
14. Fitzal F, Redl H, Strohmaier W, et al. A 4-amino analogue of tetrahydrobiopterin attenuates endotoxin-induced hemodynamic alterations and organ injury in rats. Shock 2002; 18: 158.
15. Brandacher G, Zou Y, Obrist P, et al. The 4-amino analogue of tetrahydrobiopterin efficiently prolongs murine cardiac-allograft survival. J Heart Lung Transplant 2001; 20: 747.
16. Matsuura A, Abe T, Yasuura K. Simplified mouse cervical heart transplantation using a cuff technique. Transplantation 1991; 51: 896.
17. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
18. Green LC, Wagner DA, Glogowski J, et al. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126: 131.
19. Barrett T, Suzek TO, Troup DB, et al. NCBI GEO: mining millions of expression profiles-database and tools. Nucleic Acids Res 2005; 33: D562.
20. Lewis NP, Tsao PS, Rickenbacher PR, et al. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 1996; 93: 720.
21. Szabolcs MJ, Ma N, Athan E, et al. Acute cardiac allograft rejection in nitric oxide synthase-2(-/-) and nitric oxide synthase-2(+/+) mice: effects of cellular chimeras on myocardial inflammation and cardiomyocyte damage and apoptosis. Circulation 2001; 103: 2514.
22. Szabolcs MJ, Sun J, Ma N, et al. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection. Circulation 2002; 106: 2392.
23. Koglin J, Granville DJ, Glysing-Jensen T, et al. Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis. Circulation 1999; 99: 836.
24. Pieper GM, Nilakantan V, Hilton G, et al. Variable efficacy of N6-(1-iminoethyl)-L-lysine in acute cardiac transplant rejection. Am J Physiol Heart Circ Physiol 2004; 286: H525.
25. Huisman A, Vos I, van Faassen EE, et al. Anti-inflammatory effects of tetrahydrobiopterin on early rejection in renal allografts: modulation of inducible nitric oxide synthase. FASEB J 2002; 16: 1135.
26. Werner ER, Gorren AC, Heller R, et al. Tetrahydrobiopterin and nitric oxide: mechanistic and pharmacological aspects. Exp Biol Med (Maywood) 2003; 228: 1291.
27. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271: C1424.
28. Akizuki E, Akaike T, Okamoto S, et al. Role of nitric oxide and superoxide in acute cardiac allograft rejection in rats. Proc Soc Exp Biol Med 2000; 225: 151.
29. Erickson LM, Pan F, Ebbs A, et al. Microarray-based gene expression profiles of allogratt rejection and immunosuppression in the rat heart transplantation model. Transplantation 2003; 76: 582.
30. Christopher K, Mueller TF, Ma C, et al. Analysis of the innate and adaptive phases of allograft rejection by cluster analysis of transcriptional profiles. J Immunol 2002; 169: 522.
31. Saiura A, Mataki C, Murakami T, et al. A comparison of gene expression in murine cardiac allografts and isografts by means DNA microarray analysis. Transplantation 2001; 72: 320.
32. Ho S, Clipstone N, Timmermann L, et al. The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 1996; 80: S40.
33. Thoeni G, Stoitzner P, Brandacher G, et al. Tetrahydro-4-aminobiopterin attenuates dendritic cell-induced T cell priming independently from inducible nitric oxide synthase. J Immunol 2005; 174: 7584.
34. Buerke M, Murohara T, Skurk C, et al. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci U S A 1995; 92: 8031.
35. Elzaouk L, Leimbacher W, Turri M, et al. Dwarfism and low insulin-like growth factor-1 due to dopamine depletion in Pts-/- mice rescued by feeding neurotransmitter precursors and H4-biopterin. J Biol Chem 2003; 278: 28303.
36. Blau N, Erlandsen H. The metabolic and molecular bases of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Mol Genet Metab 2004; 82: 101.
37. Channon KM. Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med 2004; 14: 323.
38. Ramzy D, Rao V, Tumiati LC, et al. Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction. Transplantation 2005; 79: 876.